NCT00637819View on ClinicalTrials.gov

Leflunomide in Systemic Lupus Erythematosus

PHASE2CompletedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

July 31, 2004

Conditions

Systemic Lupus Eythematosus (SLE)

Interventions

DRUG

Leflunomide

A loading dose of LEF 100mg daily for 3 days, followed by LEF 20mg daily for the remainder of the study or matching placebo

Trial Locations (1)

Unknown

Sanofi-Aventis, Hong Kong

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00637819 - Leflunomide in Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter